15 Frequently Asked Questions : HIPEC Cancer Surgery in India for Congolese Patients

Q1 · What Is HIPEC Cancer Surgery and When May a Congo Patient Need It?

HIPEC stands for Hyperthermic Intraperitoneal Chemotherapy. It is generally performed in combination with cytoreductive surgery (CRS). The treatment has two major components:

1. Cytoreductive Surgery

The surgeon removes visible tumour deposits from the abdominal cavity. Depending on the cancer, this may involve removal of part of an organ, sections of bowel, the appendix, ovaries, peritoneal tissue or other affected structures.

2. HIPEC

After visible tumour has been removed, heated chemotherapy is circulated directly inside the abdominal cavity for a defined period.

The aim is to expose the abdominal surfaces to a high concentration of chemotherapy after surgical removal of visible disease. HIPEC is therefore different from conventional chemotherapy, which is commonly delivered through a vein or other systemic route.

HIPEC may be considered for selected patients with

• Appendix cancer
• Pseudomyxoma peritonei
• Colorectal cancer with peritoneal spread
• Selected ovarian cancers
• Gastric cancer with appropriate peritoneal involvement
• Peritoneal mesothelioma
• Primary peritoneal cancer
• Selected other abdominal cancers

Q2 · What Is the Cost of HIPEC Cancer Surgery in India Compared with Congo?

The cost of CRS with HIPEC varies significantly because it is a complex operation and the extent of cytoreductive surgery differs between patients. For planning purposes:

Indicative Cost Comparison

Current Indian sources describe HIPEC costs as highly variable depending on cancer type, complexity, hospital, surgeon, ICU stay and chemotherapy drugs. Published planning estimates also vary considerably, so Congo patients should obtain a patient-specific quotation after medical records have been reviewed. Important: These figures are indicative planning estimates and are not fixed hospital quotations. The final cost may increase if the surgery is extensive, ICU care is required, complications occur, additional organs need to be removed, or further cancer treatment is needed.

Q3 · Which Indian Cities Can Congo Patients Consider for HIPEC Cancer Surgery?

HIPEC requires specialised surgical, anaesthesia, intensive-care and oncology support. Patients should therefore confirm that the selected centre performs CRS with HIPEC for the specific cancer type rather than assuming that all cancer hospitals provide the procedure.

Q4 · Which Hospitals in India Can Congo Patients Consider for HIPEC Cancer Surgery?

Important: This is the established city-wise hospital list for this guide format. Not every hospital listed necessarily performs CRS with HIPEC for every cancer type. Patients should specifically confirm procedure availability and the relevant surgical oncology team before travelling.

Q5 · What Types of Cancer May Be Treated with CRS and HIPEC?

HIPEC is primarily considered for selected cancers involving the abdominal cavity and peritoneal surfaces.

Appendix Cancer

HIPEC may be considered for selected appendiceal tumours and pseudomyxoma peritonei.

Colorectal Cancer

Some patients with colorectal cancer that has spread to the peritoneum may be evaluated for CRS with HIPEC.

Ovarian Cancer

Selected patients with ovarian cancer involving the peritoneal surfaces may be considered.

Gastric Cancer

Some patients with gastric cancer and appropriate peritoneal disease may be evaluated.

Peritoneal Mesothelioma

Selected patients with peritoneal mesothelioma may undergo CRS with HIPEC.

Primary Peritoneal Cancer

Patients with selected primary peritoneal malignancies may be considered.

The exact indication depends on disease distribution, tumour biology, previous treatment and whether adequate cytoreduction can be achieved.

Q6 · Who May Be Considered for HIPEC Treatment?

A patient may be evaluated for CRS with HIPEC when

• The cancer involves the peritoneal cavity
• The disease is potentially amenable to surgical cytoreduction
• The patient's general condition permits major surgery
• Organ function is adequate
• The disease distribution is considered manageable
• The cancer type is one for which CRS/HIPEC may be appropriate
• Previous treatment and response are considered suitable

Doctors may assess the Peritoneal Cancer Index (PCI) or other measures of disease distribution when evaluating peritoneal malignancy. The presence of extensive disease outside the abdomen, poor organ function or inability to achieve meaningful tumour removal may affect eligibility. HIPEC is therefore a highly selective treatment rather than a standard procedure for every patient with abdominal cancer.

Q7 · What Are the Potential Benefits and Limitations of HIPEC?

Potential Benefits

For appropriately selected patients, CRS with HIPEC may

• Remove visible peritoneal tumour deposits
• Deliver chemotherapy directly into the abdominal cavity
• Provide a high local concentration of chemotherapy
• Treat microscopic residual disease after cytoreduction
• Form part of a multidisciplinary treatment strategy
• Offer a treatment option for selected peritoneal malignancies

Important Limitations

HIPEC is also a major procedure with significant risks.

Potential complications may include

• Infection
• Bleeding
• Anaemia
• Electrolyte abnormalities
• Blood-clot complications
• Bowel complications
• Kidney problems
• Respiratory complications
• Anastomotic leakage where bowel reconstruction is performed
• Need for prolonged ICU care
• Delayed recovery
• Additional surgery in some cases

Published Indian experience has documented substantial postoperative morbidity in some patients, highlighting the need for specialised multidisciplinary perioperative care.

Q8 · What Medical Reports Should Congo Patients Send Before Travelling for HIPEC?

A complete medical record is especially important because HIPEC eligibility depends heavily on the extent and distribution of disease.

Patients should provide

• Biopsy report
• Histopathology report
• Immunohistochemistry report
• Molecular testing where available
• CT scan
• MRI where applicable
• PET-CT where appropriate
• Previous operative reports
• Previous chemotherapy records
• Previous radiotherapy records
• Colonoscopy report where applicable
• Endoscopy report where applicable
• Blood investigations
• Kidney-function tests
• Liver-function tests
• Tumour-marker results where relevant
• Current medication list

Patients should also provide a short clinical history including

• Age
• Exact cancer diagnosis
• Date of diagnosis
• Current cancer stage if known
• Previous treatment
• Response to treatment
• Current symptoms
• Other significant medical conditions

If imaging is available electronically, the complete image files should be provided rather than only the written radiology report whenever possible.

Q9 · What Is the Typical Process for HIPEC Treatment in India?

Step 1: Medical Record Review

The Indian oncology team reviews the pathology, imaging and previous treatment.

Step 2: Disease Assessment

The team evaluates the location and extent of peritoneal disease.

Step 3: Multidisciplinary Consultation

Surgical oncology, medical oncology, radiology, pathology and anaesthesia teams may be involved.

Step 4: Eligibility Assessment

The team determines whether meaningful cytoreduction appears achievable and whether the patient can safely undergo major surgery.

Step 5: Pre-Operative Investigations

Blood tests, cardiac assessment, anaesthesia evaluation and additional imaging may be required.

Step 6: Cytoreductive Surgery

Visible tumour deposits are surgically removed.

Step 7: HIPEC

Heated chemotherapy is circulated within the abdominal cavity according to the selected treatment protocol.

Step 8: Postoperative Monitoring

The patient is monitored closely for fluid balance, temperature, kidney function, blood counts, infection, bowel function and other complications.

Step 9: Pathology Review

Removed tissues are examined to establish the final pathological findings.

Step 10: Further Cancer Treatment

Depending on the diagnosis and final pathology, additional systemic chemotherapy or other cancer treatment may be recommended.

Q10 · Are There Alternatives to HIPEC?

Yes. HIPEC is only one possible treatment approach.

Depending on the cancer and stage, alternatives may include

• Systemic chemotherapy
• Targeted therapy
• Immunotherapy
• Hormonal treatment
• Conventional cancer surgery
• Palliative surgery
• Radiotherapy
• Interventional oncology
• Supportive and symptom-directed treatment
• Clinical trials where available

For some patients, systemic treatment may be recommended instead of CRS with HIPEC. The appropriate approach depends on the cancer type, molecular characteristics, extent of disease, previous treatment and overall health.

Q11 · What Should Congo Patients Ask Before Accepting a HIPEC Quotation?

Before travelling or confirming treatment, patients should ask

• Is CRS with HIPEC appropriate for this exact cancer?
• What is the current cancer stage?
• How extensive is the peritoneal disease?
• Has the imaging been reviewed by the surgical oncology team?
• What is the expected extent of cytoreductive surgery?
• Which organs or bowel segments may need to be removed?
• Is bowel reconstruction likely?
• What HIPEC chemotherapy drug will be used?
• Is the HIPEC drug included in the quotation?
• Are ICU charges included?
• Are blood products included?
• Is pathology included?
• How many hospital days are expected?
• What complications could increase the cost?
• Will chemotherapy or other cancer treatment be required after HIPEC?

Patients should request a detailed written estimate rather than relying only on a basic surgery price.

Q12 · How Long Should Congo Patients Stay in India for HIPEC?

HIPEC involves major abdominal surgery and usually requires a longer recovery period than many routine operations. Published Indian experience has reported a median hospital stay of approximately 12 days, although individual stays vary significantly.

For international patients, planning may include

• Initial consultation and investigations: approximately 3–7 days
• Hospitalisation: approximately 10–21 days in many planning scenarios
• Extended hospitalisation: possible when complications or slow recovery occur
• Post-discharge recovery in India: additional time may be advisable before international travel

The actual stay depends on

• Extent of cytoreduction
• Number of organs involved
• Bowel surgery
• ICU requirement
• Nutritional recovery
• Infection
• Kidney function
• Bowel function
• Overall postoperative recovery

Patients should avoid booking a fixed return date immediately after surgery.

Q13 · What Is Recovery Like After HIPEC Surgery?

Recovery after CRS with HIPEC can be considerably longer than after routine cancer surgery.

Early postoperative care may include

• Pain control
• IV fluids
• Nutritional support
• Blood-count monitoring
• Electrolyte monitoring
• Kidney-function monitoring
• Infection prevention
• Breathing exercises
• Early mobilisation
• Physiotherapy
• Bowel-function monitoring
• Wound care

Patients may initially experience

• Fatigue
• Abdominal discomfort
• Reduced appetite
• Weakness
• Temporary bowel changes
• Weight loss
• Reduced physical stamina

Recovery may require gradual increases in walking and physical activity.

The patient should receive clear instructions regarding

• Wound care
• Diet
• Medicines
• Activity
• Lifting restrictions
• Bowel function
• Follow-up investigations
• Warning signs

Q14 · How Can Congo Patients Continue Follow-up After Returning Home?

Before returning to Congo, patients should collect their complete treatment documentation.

This should include

• Final diagnosis
• Operative report
• HIPEC treatment summary
• Final histopathology
• Immunohistochemistry
• Molecular testing where applicable
• Imaging reports
• Imaging copies
• Chemotherapy summary
• Medication list
• Discharge summary
• Recommended follow-up schedule

Follow-up may involve

• Clinical examination
• Blood tests
• Tumour markers where appropriate
• CT scans
• MRI where required
• Assessment of nutritional recovery
• Monitoring bowel function
• Monitoring for recurrence
• Further chemotherapy where indicated

The Indian oncology team should provide a clear follow-up plan that can be continued with an oncology team in Congo.

Patients should seek prompt medical attention for

• Fever
• Severe abdominal pain
• Persistent vomiting
• Abdominal swelling
• Wound discharge
• Significant bleeding
• Breathing difficulty
• Severe weakness
• Reduced urine output
• Sudden deterioration

Q15 · Is India an Option for Congo Patients Seeking HIPEC Cancer Surgery?

India can be considered by Congo patients seeking specialist evaluation for CRS with HIPEC, particularly when the cancer involves the peritoneal surfaces and the patient is seeking a specialised multidisciplinary assessment. However, international treatment should not be based on the availability of HIPEC alone.

Before travelling, patients should compare

• Exact cancer diagnosis
• Histopathology
• Cancer stage
• Distribution of peritoneal disease
• Previous chemotherapy
• Response to treatment
• Surgical resectability
• Expected extent of cytoreduction
• HIPEC protocol
• Surgical team's experience
• ICU and postoperative facilities
• Total estimated treatment cost
• Expected hospital stay
• Follow-up requirements

A specialist second opinion based on complete imaging and pathology can help determine whether CRS with HIPEC is an appropriate treatment option before the patient travels.